Poppin' Jay Inc. DBA Continuum Clinical – Trademark Portfolio
Entity Type: 03
Poppin' Jay Inc. DBA Continuum Clinical holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MERIS. The owner is based in Northbrook, IL.
650 Dundee Road Suite 250
Northbrook, IL 60062
Showing of trademarks Trademarks
Trademark Classifications
Poppin' Jay Inc. DBA Continuum Clinical's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Poppin' Jay Inc. DBA Continuum Clinical have?
Poppin' Jay Inc. DBA Continuum Clinical has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Poppin' Jay Inc. DBA Continuum Clinical file in?
Poppin' Jay Inc. DBA Continuum Clinical files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are Poppin' Jay Inc. DBA Continuum Clinical's most well-known trademarks?
Poppin' Jay Inc. DBA Continuum Clinical's registered trademark portfolio includes well-known marks such as MERIS. These are among 1 currently registered trademark in the portfolio.
What is Poppin' Jay Inc. DBA Continuum Clinical's trademark registration success rate?
Poppin' Jay Inc. DBA Continuum Clinical has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.